Execution of Nirbhaya convicts won't take place on Jan 22: Standing Counsel for Tihar Jail authorities

Image
ANI General News
Last Updated : Jan 15 2020 | 3:30 PM IST

Standing Counsel for Tihar Jail authorities Advocate Rahul Mehra on Wednesday said that the execution of convicts in the 2012 Nirbhaya gang-rape and murder case will not take place on January 22.

He further stated that the fate of a death convict comes to finality only after his mercy plea is rejected by the President

"It can only take place 14 days after the mercy plea is rejected as we are bound by the rule which says that a notice of 14 days must be provided to the convicts after the rejection of mercy plea," he added.

Mukesh Singh, one of the four convicts in the gang-rape and murder of paramedic student in 2012, has informed the Delhi High Court that his mercy petition is pending before the Lieutenant Governor of Delhi and the President of India and he should be given a minimum 14 days notice between the rejection of his mercy petition and scheduled date of execution.

Meanwhile, the Delhi High Court has refused to set aside the trial court order which issued death warrant.

Delhi High Court had asked convict Mukesh's counsel to approach trial court and apprise the court about the pending mercy plea.

The Supreme Court had already dismissed curative petitions of the two death row convicts, including Mukesh Singh, in 2012 gang-rape case.

Vinay Sharma and Mukesh Singh had moved the curative petitions in the top court after a Delhi court issued death warrants in their names for their hanging on January 22.

Besides them, two other convicts named Pawan and Akshay are also slated to be executed on the same day at 7 am in Delhi's Tihar Jail premises.

They were convicted and sentenced to death for raping a 23-year-old woman in a moving bus in the national capital on the intervening night of December 16-17, 2012.

The victim, who was later given the name Nirbhaya, had succumbed to injuries at a hospital in Singapore where she had been airlifted for medical treatment.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 15 2020 | 3:15 PM IST

Next Story